Use of selenium-silymarin mix reduces lower urinary tract symptoms and prostate specific antigen in men
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15310%2F13%3A33144114" target="_blank" >RIV/61989592:15310/13:33144114 - isvavai.cz</a>
Alternative codes found
RIV/61989592:15110/13:33144114 RIV/00098892:_____/13:#0000494
Result on the web
<a href="http://www.phytomedicinejournal.com/article/S0944-7113(13)00281-X/abstract" target="_blank" >http://www.phytomedicinejournal.com/article/S0944-7113(13)00281-X/abstract</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.phymed.2013.07.018" target="_blank" >10.1016/j.phymed.2013.07.018</a>
Alternative languages
Result language
angličtina
Original language name
Use of selenium-silymarin mix reduces lower urinary tract symptoms and prostate specific antigen in men
Original language description
The aim of this double-blind, placebo controlled clinical trial was to assess the effects of a combination of selenium and silymarin in men with lower urinary tract symptoms, benign prostatic hyperplasia and a prostate specific antigen (PSA) ?2.5ng/ml. The volunteers were randomized to two groups: the first one (n=26) received 240?g selenium (in the form of yeast l-selenomethionine) plus 570mg silymarin daily for 6 months and the second (n=29) received placebo. Outcome measures were changes in the International Prostate Symptom Score (IPSS), bladder volume (V), urinary flow rate, ultrasound estimated postvoid residual urine volume (RV), serum PSA, testosterone and selenium levels, safety clinical biochemistry, hematology and oxidative stress parametersat baseline and on day 180. The results showed statistically significant differences (p{0.05) between treatment and control groups for the following parameters: IPSS score, urodynamic parameters: maximal rate of urine flow (Qmax), averag
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
CE - Biochemistry
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Phytomedicine
ISSN
0944-7113
e-ISSN
—
Volume of the periodical
21
Issue of the periodical within the volume
1
Country of publishing house
DE - GERMANY
Number of pages
7
Pages from-to
75-81
UT code for WoS article
—
EID of the result in the Scopus database
—